How has coronavirus affected research houses trying to rate funds?
‘Actually we’ve been able to gather as much information via Zoom’
Fe
-
-
Rival research houses link up to launch fund dashboard
Square Mile and FE Fundinfo product to go live in Q1 2020
-
Sophie Meatyard: Is there a cure for ‘misbehaving’ pharma?
Sector trailing other traditional late cycle winners despite strong earnings growth
-
Schroders and Axa IM dropped in FE rebalance
Blackrock and Liontrust head the list of groups with the most top-rated funds
-
Why were investors so surprised about Woodford’s lack of liquidity?
Woodford problems compounded in a similar way to Gam, says FE analyst Louis Tambe
-
How the European Parliamentary elections could impact markets
FE investment analyst Sophie Meatyard on how passing laws could become more difficult
-
Tanvi Kandlur: The case for and against Japanese equity valuations
Recession risks are heightened if Japan goes ahead with a consumption tax hike
-
FE: More to Aim market than meets the eye
Index is riskier than larger contemporaries but has outgrown its reputation as a home for domestically focused micro-caps
-
FE cuts 52 managers from alpha list
Axa IM’s Chris St John is among UK equity managers to have lost the title
-
Louis Tambe: Why 2018 wasn’t that bad for absolute return
‘Hedged’ versus ‘multi-asset’ makes a difference to performance, argues FE
-
Charles Younes: Why sterling corporate bond funds are suffering
Credit quality hits star funds in low beta fixed income sectors
-
Rob Gleeson: Soft Brexit could challenge portfolio managers
FE’s head of research examines the ‘good news is bad for markets’ paradigm
